Breaking News, Collaborations & Alliances

GeoVax Expands Collaboration with Leidos

To develop malaria vaccine candidates

GeoVax Labs, Inc. has expanded its collaboration with Leidos, Inc. to develop malaria vaccine candidates.     The work will be supported under a contract to Leidos from the United States Agency for International Development (USAID) Malaria Vaccine Development Program (MVDP). Leidos has been tasked by USAID to advance promising vaccine candidates against P. falciparum malaria and selected the GeoVax MVA-VLP platform as part of this development effort. GeoVax’s vaccine technology is...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters